RNL-Astrostem®, adipose-derived mesenchymal stem cells for treatment of spinal cord injury
RNL-Astrostem® are autologous adipose-derived mesenchymal stem cells (Adipose-MSCs) used for treatment of a wide range of diseases. This study aims to assess the safety of intravenous autologous adipose-MSCs transplantation in spinal cord injury patients.
Read More
Product Information for
RNL-Astrostem®, adipose-derived mesenchymal stem cells for treatment of spinal cord injury
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access